[ad_1]
The Department of Medicine Administration did not authorize the kit test ‘ Co Rapid Dot Blot ‘to detect the coronavirus invented by scientists at the public health center. (April 30) A notification has been sent to the media.
Director General of the Department of Drug Administration, Major General. The press release signed by Mahbubur Rahman said various media reports that the GR Covid-19 Rapid Spot Erase Immunoassay Kit invented by Messrs. Gonoshastha Pharmaceuticals Limited has been approved by the Department of Drug Administration for testing . Which is not correct. Permission has been granted for the application of Public Health Pharmaceuticals Limited to conduct the Kit Performance Test in accordance with all rules approved by the Drug Administration, CR0-3: ICDDRB and CR0-10: BSMMU.
The notification also said that the next necessary action will be taken based on the results obtained at the end of these performance tests.
Previous news about:
Permission has been granted, public health kit goes to trial
[ad_2]
